Riktkurs.nu
EN | SV
CalliditasMid CapCellavision
Stockholm Stock Exchange | Mid Cap
Camurus
+16.25%
Latest
+13.27%
3 months
Pareto SecuritiesCarnegieBryan GarnierNordea MarketsDNBJefferiesHandelsbankenDNB Markets

Price Targets For Camurus

AnalystPrice TargetDateUpside
Pareto Securities332 SEKMay 25
+16.25%
Carnegie315 SEKMay 3
Bryan Garnier320 SEKFeb 14
Nordea Markets305 SEKNov -22
DNB310 SEKSep -22
Jefferies205 SEKApr -22
Handelsbanken235 SEKDec -21
DNB Markets275 SEKNov -21

About The Company

Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases.
Wikipedia

The information on Riktkurs.nu is for general information purposes only. Riktkurs.nu makes no guarantees of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to Riktkurs.nu or the information, products, services, or related information on Riktkurs.nu for any purpose. The recipient is recommended to complete his or her decision basis with the material deemed necessary. We reserve us for all types of errors as well as any malfunctions of the website. The information on Riktkurs.nu should not be seen as a recommendation to buy or sell a security.
© Riktkurs.nu 2023